Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)
CUSIP: 90400D108
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 98,459,627
- Total 13F shares
- 86,896,233
- Share change
- -1,530,900
- Total reported value
- $4,824,969,188
- Put/Call ratio
- 82%
- Price per share
- $55.55
- Number of holders
- 299
- Value change
- -$72,319,917
- Number of buys
- 164
- Number of sells
- 121
Quarterly Holders Quick Answers
What is CUSIP 90400D108?
CUSIP 90400D108 identifies RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 90400D108:
Top shareholders of RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
9.9%
|
9,780,493
|
$401,978,262 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.7%
|
5,603,352
|
$230,297,768 | — | 30 Jun 2024 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.4%
|
5,354,750
|
$220,080,225 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
4.6%
|
4,556,167
|
$187,258,464 | — | 30 Jun 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
3.3%
|
3,259,927
|
$133,983,000 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3%
|
2,991,958
|
$122,970,000 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
2,697,101
|
$110,850,851 | — | 30 Jun 2024 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.4%
|
2,353,804
|
$96,741,330 | — | 30 Jun 2024 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.3%
|
2,241,832
|
$92,139,295 | — | 30 Jun 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2.1%
|
2,107,025
|
$86,598,728 | — | 30 Jun 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
2,061,426
|
$84,724,609 | — | 30 Jun 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
2%
|
1,924,072
|
$79,079,359 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.9%
|
1,850,734
|
$76,065,167 | — | 30 Jun 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.8%
|
1,800,000
|
$73,980,000 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.8%
|
1,782,340
|
$73,254,174 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.6%
|
1,527,875
|
$62,795,663 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,505,458
|
$61,891,491 | — | 30 Jun 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.5%
|
1,466,547
|
$60,275,082 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.3%
|
1,268,318
|
$52,127,869 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.2%
|
1,133,100
|
$46,570,410 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.1%
|
1,125,000
|
$46,237,500 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
1%
|
1,002,463
|
$41,201,229 | — | 30 Jun 2024 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.98%
|
963,146
|
$39,585,301 | — | 30 Jun 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.98%
|
960,000
|
$39,456,000 | — | 30 Jun 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.84%
|
830,375
|
$34,128,000 | — | 30 Jun 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.84%
|
830,000
|
$34,113,000 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.79%
|
781,943
|
$32,137,862 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.73%
|
716,947
|
$29,466,520 | — | 30 Jun 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.7%
|
688,942
|
$28,314,195 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
0.66%
|
647,618
|
$26,617,100 | — | 30 Jun 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.64%
|
634,327
|
$26,070,840 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.64%
|
629,514
|
$25,873,045 | — | 30 Jun 2024 | |
| Man Group plc |
13F
|
Company |
0.64%
|
628,726
|
$25,840,638 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.58%
|
568,309
|
$23,357,500 | — | 30 Jun 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.57%
|
556,818
|
$22,885,220 | — | 30 Jun 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
548,905
|
$22,559,996 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.56%
|
547,818
|
$22,515,320 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.55%
|
539,749
|
$22,183,696 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.55%
|
537,616
|
$22,096,018 | — | 30 Jun 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.54%
|
528,180
|
$21,708,198 | — | 30 Jun 2024 | |
| Eagle Health Investments LP |
13F
|
Company |
0.53%
|
524,500
|
$21,556,950 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.51%
|
497,969
|
$20,466,576 | — | 30 Jun 2024 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.49%
|
486,682
|
$20,002,630 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.45%
|
442,200
|
$18,174,420 | — | 30 Jun 2024 | |
| AXA S.A. |
13F
|
Company |
0.43%
|
425,334
|
$17,481,227 | — | 30 Jun 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.43%
|
425,000
|
$17,467,500 | — | 30 Jun 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.42%
|
415,000
|
$17,056,500 | — | 30 Jun 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.41%
|
406,519
|
$16,708,000 | — | 30 Jun 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.4%
|
390,592
|
$16,053,331 | — | 30 Jun 2024 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.4%
|
390,524
|
$16,050,536 | — | 30 Jun 2024 |
Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q3 2024
As of 30 Sep 2024,
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) was held by
299 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
86,896,233 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., SANDS CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, ALKEON CAPITAL MANAGEMENT LLC, STATE STREET CORP, Clearbridge Investments, LLC, FEDERATED HERMES, INC., and Rock Springs Capital Management LP.
This page lists
300
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
273
Q3 2024 holders
299
Holder diff
26
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.